BU-NOT-SET

CONTACT US
The outlook for a year of change
  • Industry trends
Eyes
Insight
Can oral solid dose keep its place as the leading dosage form?
  • Drug product
Eyes
Insight
Relocating API supply to avoid over-reliance
  • Drug substance
Eyes
Insight
Modified release fixed dose combination product with two poorly soluble drug substances
  • Drug product
pellets
Case study
Patient centricity during drug development and commercialisation
  • Drug product
Eyes
Insight
10 considerations to kick-start your drug development journey
  • Drug product
Eyes
Insight
Guidance for start-ups on drug development
  • Drug product
Eyes
Insight
Drug development for start-ups
  • Drug product
  • Drug substance
Test tubes
White paper
Optimising environmental sustainability
  • Sustainability
Eyes
Insight
Case study
  • Drug product
  • Manufacturing
Overcoming fixed-dose combination challenges for ALS
Video
  • Industry trends
What’s shaping the future of pharma?
Insight
  • Drug product
  • Manufacturing
Mastering tech-transfer: Turning complexity into competitive advantage
Insight
  • Drug product
  • Manufacturing
Four ways ReciPredict can transform your pharma manufacturing
Insight
  • Analytical chemistry
  • Industry trends
An expert’s guide to analytical services
Insight
  • Drug product
  • Manufacturing
How lyophilisation can help overcome mRNA stability challenges
Insight
  • Drug product
  • Manufacturing
How pre-filled syringes are changing drug delivery of biologics
Webinar
  • Drug product
Choosing the right sterile container for your drug product
Video
  • Manufacturing
ReciBioPharm is advancing the future of xRNA manufacturing